Literature DB >> 8549796

Differential effects of NaCl concentration on the constitutive activity of the thyrotropin and the luteinizing hormone/chorionic gonadotropin receptors.

F Cetani1, M Tonacchera, G Vassart.   

Abstract

The TSH receptor (TSHR) and the LH/CG receptor (LHR) are members of the family of G protein-coupled receptors. Recently, point mutations conferring constitutive activity to the TSHR and LHR have been observed as a cause of toxic adenoma and familial/sporadic male pseudo-precocious puberty, respectively. When evaluated by transfection in COS-7 cells the wild-type (wt) TSHR displays definite constitutive activity towards Gs-dependent adenylylcyclase stimulation, while available evidence shows that the LHR does not. In order to compare the constitutive activity of both receptors, we performed functional studies in COS-7 cells using different assay conditions. Human TSHR and LHR cDNAs subcloned in the expression vector pSVL were transiently expressed in COS-7 cells and cAMP production was determined following incubation in a medium containing physiological concentration of NaCl [isotonic (NaCl)] or in the same medium without NaCl [hypotonic (NaCl-)] or where NaCl was replaced by an isoosmolar concentration of sucrose [isotonic (sucrose)]. Cells transfected with the TSHR showed higher basal cAMP levels over cells transfected with pSVL in all conditions tested. The effect was stronger when cells were incubated in isotonic (sucrose) buffer. Cells expressing LHR exhibited a minimal increase of cAMP levels over cells transfected with pSVL in isotonic (NaCl) buffer; however, a marked increase in basal cAMP levels was observed when cells were assayed in hypotonic (NaCl-) or isotonic (sucrose) buffers. Varying the pH or incubation temperature was without effect on the results obtained with both receptors. Our data show that despite extensive sequence similarity, the LH and TSH receptors differ markedly in their basal activity. The differential sensitivity of both receptors to low NaCl concentrations, suggests that the unliganded TSH receptor is less constrained than its LH homolog and may be more susceptible to activation by a wide spectrum of mutations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8549796     DOI: 10.1016/0014-5793(95)01384-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

1.  Ras homolog enriched in striatum inhibits the functional activity of wild type thyrotropin, follicle-stimulating hormone, luteinizing hormone receptors and activating thyrotropin receptor mutations by altering their expression in COS-7 cells.

Authors:  P Agretti; G De Marco; A Pinchera; P Vitti; J Bernal; M Tonacchera
Journal:  J Endocrinol Invest       Date:  2007-04       Impact factor: 4.256

Review 2.  Modulation of GPCRs by monovalent cations and anions.

Authors:  Andrea Strasser; Hans-Joachim Wittmann; Erich H Schneider; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-11-30       Impact factor: 3.000

3.  A new small-molecule antagonist inhibits Graves' disease antibody activation of the TSH receptor.

Authors:  Susanne Neumann; Elena Eliseeva; Joshua G McCoy; Giorgio Napolitano; Cesidio Giuliani; Fabrizio Monaco; Wenwei Huang; Marvin C Gershengorn
Journal:  J Clin Endocrinol Metab       Date:  2010-12-01       Impact factor: 5.958

4.  Genetic analysis of the TSH receptor gene in differentiated human thyroid carcinomas.

Authors:  F Cetani; M Tonacchera; A Pinchera; R Barsacchi; F Basolo; P Miccoli; F Pacini
Journal:  J Endocrinol Invest       Date:  1999-04       Impact factor: 4.256

Review 5.  Immunopathogenesis of Graves' ophthalmopathy: the role of the TSH receptor.

Authors:  Seethalakshmi Iyer; Rebecca Bahn
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-06       Impact factor: 4.690

6.  A monoclonal antibody with thyrotropin (TSH) receptor inverse agonist and TSH antagonist activities binds to the receptor hinge region as well as to the leucine-rich domain.

Authors:  Chun-Rong Chen; Sandra M McLachlan; Basil Rapoport
Journal:  Endocrinology       Date:  2009-03-19       Impact factor: 4.736

7.  Identification of key amino acid residues in a thyrotropin receptor monoclonal antibody epitope provides insight into its inverse agonist and antagonist properties.

Authors:  Chun-Rong Chen; Sandra M McLachlan; Basil Rapoport
Journal:  Endocrinology       Date:  2008-04-03       Impact factor: 4.736

8.  Human alpha-subunit analogs act as partial agonists to the thyroid-stimulating hormone receptor: differential effects of free and yoked subunits.

Authors:  Krassimira Angelova; Valerie Fremont; Renita Jain; Meng Zhang; David Puett; Prema Narayan; Mariusz W Szkudlinski
Journal:  Endocrine       Date:  2004-06       Impact factor: 3.633

9.  Principles and determinants of G-protein coupling by the rhodopsin-like thyrotropin receptor.

Authors:  Gunnar Kleinau; Holger Jaeschke; Catherine L Worth; Sandra Mueller; Jorge Gonzalez; Ralf Paschke; Gerd Krause
Journal:  PLoS One       Date:  2010-03-18       Impact factor: 3.240

10.  A cell-based PDE4 assay in 1536-well plate format for high-throughput screening.

Authors:  Steven A Titus; Xiao Li; Noel Southall; Jianming Lu; James Inglese; Michael Brasch; Christopher P Austin; Wei Zheng
Journal:  J Biomol Screen       Date:  2008-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.